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Background: The ability to drive is important for ensuring quality of life for many older adults. Glaucoma is
prevalent in this age group and may affect driving. The purpose of this study is to determine if glaucoma and
glaucomatous visual field (VF) loss are associated with driving cessation, limitations, and deference to another driver
in older adults.
Methods: Cross-sectional study. Eighty-one glaucoma subjects and 58 glaucoma suspect controls between age 60
and 80 reported if they had ceased driving, limited their driving in various ways, or preferred another to drive.
Results: Twenty-three percent of glaucoma subjects and 6.9% of suspects had ceased driving (p = 0.01). Glaucoma
subjects also had more driving limitations than suspects (2.0 vs. 1.1, p = 0.007). In multivariable models, driving
cessation was more likely for glaucoma subjects as compared to suspects (OR = 4.0; 95% CI = 1.1-14.7; p = 0.03). The
odds of driving cessation doubled with each 5 decibel (dB) decrement in the better-eye VF mean deviation (MD)
(OR = 2.0; 95% CI = 1.4-2.9; p < 0.001). Glaucoma subjects were also more likely than suspects to report a greater
number of driving limitations (OR = 4.7; 95% CI = 1.3-16.8; p = 0.02). The likelihood of reporting more limitations
increased with the VF loss severity (OR = 1.6 per 5 dB decrement in the better-eye VF MD; 95% CI = 1.1-2.4; p = 0.02).
Neither glaucoma nor VF MD was associated with other driver preference (p > 0.1 for both).
Conclusions: Glaucoma and glaucomatous VF loss are associated with greater likelihood of driving cessation and
greater limitation of driving in the elderly. Further prospective study is merited to assess when and why people
with glaucoma change their driving habits, and to determine if their observed self-regulation of driving is adequate
to ensure safety.Background
Over 60 million people worldwide are affected by glau-
coma, a number that will increase substantially as the
population ages [1]. Glaucoma prevalence is highest
among the elderly, and elderly individuals with glaucoma
are more likely to be visually disabled because of more
advanced visual field (VF) loss and other age-related
factors [2].
Driving is highly valued by older adults because it is
often required for independence [3]. Furthermore, driv-
ing cessation is associated with incident depression and
increased risk of entry into a long term care facility, even
after controlling for demographic and health variables
[3]. Indeed, the ability to travel outside the home is con-
sistently ranked as one of the two most important visual
functions by people with glaucoma [4,5].* Correspondence: pramulu1@jhmi.edu
Wilmer Eye Institute, Johns Hopkins University, 600 N. Wolfe St., Baltimore,
MD 21287, USA
© 2013 van Landingham et al.; licensee BioMe
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumDrivers with glaucoma perceive greater difficulty with
driving, and perceived difficulty increases with severity
of VF loss [6]. Drivers with glaucoma have also been
shown to make more driving errors during driving simu-
lator and on-road evaluation of driving [7,8]. Some stud-
ies have also shown that VF loss severity is associated
with increased motor vehicle accidents (MVAs) [9-11],
though others have shown that a glaucoma diagnosis is
not associated with more accidents [12,13].
One explanation for why glaucoma does not consist-
ently increase accident risk in all studied populations is
that individuals with more advanced disease may limit
or stop driving [12,14-16]. Here, we examine how driv-
ing patterns (driving limitation, driving cessation, and
other driver preference) differ in glaucoma patients
across a range of VF loss severities.d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Subjects
This is a cross-sectional study of subjects recruited from
the Glaucoma Clinic at the Wilmer Eye Institute of
Johns Hopkins Hospital between July 2009 and June
2011. Subjects’ charts were prescreened for eligibility.
Eligible subjects had to be between the ages of 60–80 -
years and be former or current drivers.
Glaucoma subjects were restricted to those having a
physician diagnosis of primary open angle glaucoma, pri-
mary angle closure glaucoma, pseudoexfoliation glau-
coma, or pigment dispersion glaucoma. Most glaucoma
subjects had 24–2 VF tests within the 15 months prior
to enrollment from a Humphrey Field Analyzer II (Carl
Zeiss Meditec, Dublin CA) using the Standard Swedish
Interactive Testing Algorithm showing a VF MD worse
than −3 dB and a borderline or abnormal GHT result in
both eyes. Individuals whose most recent fields were
10–2 VFs were also included, in which case their better-
eye MD was defined using the last recorded 24–2 VFs.
Glaucoma suspect controls were recruited from
patients with a chart diagnosis of ocular hypertension or
glaucoma suspect. They were required to have a
presenting visual acuity of 20/40 or better in both eyes
and 24–2 VF tests within the 15 months prior to enroll-
ment indicating a mean deviation (MD) better than −5
decibels (dB) in both eyes and normal or borderline
glaucoma hemifield test (GHT) results.
This study was approved by the Johns Hopkins Institu-
tional Review Board. All subjects gave informed consent.
Evaluation of driving habits
Driving habits were evaluated with an interviewer-
administered questionnaire taken from the Salisbury Eye
Evaluation Driving Study (SEEDS), which added add-
itional questions to other questionnaires previously used
in the Salisbury Eye Evaluation [17,18]. Subjects were
asked, “Have you driven a car in the past three months?”
to assess driving cessation. In those who were currently
driving, 9 different driving limitations were assessed: (1)
not driving outside of the mid-Atlantic region (defined
for this Baltimore-based study as Maryland, Virginia,
Delaware, the District of Columbia and Pennsylvania),
(2) not driving more than one hour away from home, (3)
not driving to neighboring towns or areas, (4) not driv-
ing beyond the neighborhood, (5) not driving in the rain,
(6) not driving at night, (7) not driving in unfamiliar
areas, (8) driving less than twice per week, and (9) driv-
ing less than 5,000 miles (the standard for restricted
driving in Maryland). Each of these limitations was
assessed for the past year except for driving at night and
driving in unfamiliar areas, which were assessed for the
past three months. The questionnaire asked whether a
person had performed a particular driving activity at allduring the appointed time frame, not if they avoided that
particular driving activity or if they were legally
prohibited from doing it.
Driver preference was assessed by asking subjects, “in
a typical week when you travel in a car, how often are
you the driver?” Subjects who reported that they were
the driver 50% or less of the time they rode in a car were
considered to prefer another driver.
Measurement of vision and covariates
Monocular visual acuities were measured using the Early
Treatment Diabetic Retinopathy Study (ETDRS) chart
transilluminated at 130 candelas/m2 and converted to
the logarithm of the minimum angle of resolution
(logMAR) for use in statistical analysis [19]. VF MD
results were extracted from the chart. VF and visual acu-
ity of the better-seeing eye were used for further ana-
lysis. Binocular contrast sensitivity (CS) was measured
using the Pelli-Robson chart at 1 meter with subjects
wearing their usual correction and converted into log
units for analysis [20].
Both eyes were examined after pupillary dilation for
significant lenticular changes defined as nuclear sclerosis
greater than grade 2 on the Wilmer Cataract Grading
system [21], blocked retroillumination in ≥4/16 of the
pupil due to cortical changes, any opacity in the central
3 mm of the posterior capsule, or, in pseudophakic eyes,
posterior capsular opacification (PCO) demonstrating
changes more severe than the “mild” image in Findl et al
[22].
Demographic information collected included age, gen-
der, race, employment status, years of education
completed, living situation (if the subject lives with any
other adults), and marital status, all by self-report. Cog-
nitive ability was assessed using the Mini Mental Status
Exam (MMSE) for the Visually Impaired [23]. Depressive
symptoms were detected using the Geriatric Depression
Scale Short Form, with subjects demonstrating 6 or
more positive responses considered to have depressive
symptoms [24]. Medical comorbidities were assessed
using a standardized structured medical history ques-
tionnaire and summarized as the number of comorbid
conditions present [25]. We inquired about arthritis,
broken or fractured hip, back problems, heart attack/
myocardial infarction, angina/chest pain, congestive
heart failure, peripheral vascular disease, hypertension,
diabetes, emphysema, asthma, stroke, Parkinson’s, can-
cer (other than skin cancer), and vertigo/Meniere’s.
Statistical analysis
Group differences for continuous variables were evaluated
using the Wilcoxon rank-sum test. Chi-square analysis
was used to assess differences in categorical variables
(Stata 11.2, College Station, TX).
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preference, and the presence of each specific driving limita-
tion were assessed using univariate and multivariable logis-
tic regression models. The overall number of limitations
was assessed in univariate and multivariable ordinal logistic
regression models after trifurcating the number of driving
limitations into three categories (<3, 3–4, and >4
limitations). These categories were chosen to fulfill the
proportional odds assumption, which was verified using
the Brant test.
Results
One hundred and thirty-nine current or previous drivers
participated in this study, including 81 with glaucoma
and 58 suspects. Suspects and glaucoma subjects were
similar with regards to most health and demographic
characteristics (Table 1). Glaucoma subjects had worse
visual acuity (median logMAR of 0.15 versus 0.08 in the
better-seeing eye), worse VF results (better-eye median
VF MD of −7.9 versus +0.2 dB), worse contrast sensitiv-
ity (1.6 versus 1.9 log units), and were more likely to be
non-white when compared to suspects (Table 1).
In unadjusted analyses, more glaucoma subjects than
suspects had ceased driving (22.5% vs. 6.9%, p = 0.02).
Glaucoma subjects also had a greater mean number of
driving limitations (2.0 vs. 1.1, p = 0.004) and were more
likely to have ceased driving at night compared toTable 1 Characteristics of study participants by glaucoma sta
Glaucoma sus
Vision
Better eye visual field, MD (dB) 0.2
Binocular CS, log units 1
Better eye acuity, logMAR 0.0
Sig. cataract/PCO, either eye (%)













Continuous variables reported as median (inter-quartile range).
*P < 0.05 as compared to glaucoma suspect controls.
LogMAR = logarithm of the minimum angle of resolution; MD =mean deviation; dB
MMSE VI = Mini-Mental Status.suspects (27.4% vs. 7.4%, p = 0.005) (Table 2). Differences
between the two groups in the prevalence of all other
limitations were not statistically significant, although a
higher proportion of subjects with glaucoma endorsed
each limitation.
When adjusting for age, race, gender, unemployment,
cognition, comorbidities, and depressive symptoms,
subjects with glaucoma were four times more likely than
glaucoma suspect controls to have ceased driving (odds
ratio [OR] = 4.0; 95% CI = 1.1-14.7; p = 0.03) (Table 3).
Among glaucoma subjects, driving cessation became
more likely with more severe VF loss (OR = 2.0 for each
5 dB decrement in the better-eye MD; 95% CI = 1.4-2.9;
p < 0.001) (Figure 1). Glaucoma subjects were also likely
to report more driving limitations than glaucoma sus-
pect controls (OR = 4.7; 95% CI = 1.3-16.8; p = 0.02). The
likelihood of reporting more limitations increased with
the severity of VF loss (OR = 1.6 for each 5 dB decre-
ment in the better-eye MD; 95% CI = 1.1-2.4; p = 0.02)
(Figure 2). Significant non-visual factors associated with
driving habits included a higher risk of driving cessation
in subjects with depressive symptoms (OR = 16.5; 95%
CI = 2.2-123.7; p = 0.01) and a greater number of driving
limitations in female subjects (OR = 8.3; 95% CI = 2.0-
35.2; p = 0.004).
Additional multivariable regression models adjusting
for the same characteristics described above comparedtus
pect controls (n = 58) Glaucoma (n = 81)
(−0.7, 0.9) −7.9* (−15.4, -4.8)
.9 (1.8, 2.0) 1.6* (1.4, 1.8)
8 (0.00, 0.16) 0.15* (0.08, 0.32)
22.2 35.8
9.3 11.1
8 (65.6, 73.0) 70.3 (66.4, 74.5)
77.6 62.5*
60.3 51.3




1 (20, 22) 21 (20, 22)
2 (1, 3) 2 (1, 3)
5.2 5.9
= decibels; CS = contrast sensitivity; PCO = Posterior capsular opacification;
Table 2 Driving limitations in current drivers with and without glaucoma
Driving limitation Glaucoma suspects % (n = 54) Glaucoma% (n = 62) P value
Has not driven at night* 7 27 0.005
Has not driven in the rain 0 7 0.06
Has not driven in unfamiliar areas* 19 31 0.13
Has not driven more than one hour away 15 25 0.21
Has not driven beyond the neighborhood 0 2 0.35
Has not driven to neighboring towns or areas 2 7 0.23
Has not driven outside the region 53 71 0.05
Drives <2 times per week 2 5 0.38
Drove <5,000 miles per year 15 24 0.21
*These questions refer to the past three months. All other limitations refer to the past year.
All percentages rounded to integers.
van Landingham et al. BMC Ophthalmology 2013, 13:4 Page 4 of 7
http://www.biomedcentral.com/1471-2415/13/4the relative impact of different elements of vision (VF,
visual acuity, contrast sensitivity, and presence of cata-
ract) on driving cessation and limitations. In models that
included both VF MD and visual acuity, the associations
of VF loss with both driving cessation (OR = 1.7; 95% CI
= 1.1-2.5; p = 0.008) and driving limitation (OR = 1.6;
95% CI = 1.0-2.4; p = 0.04) persisted, as did the associ-
ation between visual acuity and driving cessation (OR =
1.3; 95% CI = 1.0-1.6; p = 0.03). In models including both
better-eye VF MD and contrast sensitivity, only the asso-
ciation between contrast sensitivity and driving cessation
(OR = 1.3; 95% CI 1.1-1.6; p = 0.002) remainedTable 3 Effect of glaucoma and glaucoma severity on driving
Variable Interval Not dri
Odds ratio
Vision
Glaucoma Present 4.0* (1.1
Better eye visual field, MD 5 dB worse 2.0* (1.4
Binocular contrast sensitivity 1 letter worse+ 1.3* (1.2
Better eye acuity, logMAR 1 line worse++ 1.5* (1.2
Demographics
Age 5 yrs older 1.2 (0.69
Race White 0.6 (0.20
Gender Female 1.3 (0.45
Unemployment Present 0.7 (0.23
Living situation Lives with others -
Marital Status Married -
Health/cognition
MMSE VI score 5 points lower 4.1 (0.85
Comorbidities 1 illness 1.0 (0.72
Depressive Symptoms Present 16.5* (2.2
Odds ratios for vision variables were each derived from separate multivariable mod
Odds ratios for non-vision variables were all derived from multivariable models incl
§Refers to current drivers only.
+Corresponds to 0.05 log unit change.
++Corresponds to 0.1 logMAR change.
*P < 0.05significant, though the two measures of vision loss were
significantly correlated (r = 0.75; p < 0.001). Finally, in
models including both cataract/PCO and better-eye VF
MD, the associations between glaucoma severity and
driving cessation (OR = 2.0; 95% CI = 1.4-2.9; p < 0.001)
and driving limitations were unchanged (OR = 1.6; 95%
CI = 1.1-2.4; p = 0.02).
Driver preference was not associated with glaucoma or
VF loss severity, even when adjusting for age, race, gen-
der, employment, living situation, marital status, and
cognition (Table 3). Preferring another driver was dra-
matically more likely in females (OR = 24.4; 95% CI =status, multivariable analysis
ving Increased limitations§ Pref. another driver§
(95% CI) Odds ratio (95% CI) Odds ratio (95% CI)
-14.7) 4.7* (1.3-16.8) 1.7 (0.54-5.3)
-2.9) 1.6* (1.1-2.4) 1.3 (0.88-2.0)
-1.4) 1.2* (1.1-1.3) 1.1 (0.92-1.2)
-1.8) 2.1* (1.3-3.5) 0.92 (0.67-1.2)
-2.0) 1.7 (0.96-3.1) 1.2* (1.0-1.3)
-1.8) 1.0 (0.31-3.5) 1.2 (0.34-4.0)
-3.7) 8.3* (2.0-35.2) 24.4* (5.0-11.8)
-2.2) 3.4 (0.88-13.0) 3.0 (0.86-10.8)
- 48.4*(1.9-1201)
- 0.91 (0.46-1.8)
-19.5) 0.22 (0.02-2.6) 19.7* (1.7-227)
-1.4) 1.20 (0.84-1.7) -
-123.7) 0.43 (0.03-5.7) -
els including all non-visual covariates shown.
uding better-eye MD and all non-visual variables shown.
Figure 1 Modeled probability of not driving as a function of
better-eye visual field loss in glaucoma patients. In addition to
better-eye mean deviation, our multivariable logistic regression
model includes age, gender, unemployment, cognition,
comorbidities, and depressive symptoms. dB = decibels.
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(OR = 46.2; 95% CI = 1.9-1094; p = 0.02), and in those
with lower cognitive ability (OR = 19.8; 95% CI = 1.7-227;
p = 0.02). No other characteristics predicted preferring
another driver (P > 0.05).Discussion and conclusions
Individuals with glaucoma were significantly more likely
than glaucoma suspects to have limited or stopped their
driving in this clinic-based study. Driving cessation and
driving limitations were also more common with more
severe VF loss (Figures 1 and 2).Figure 2 Number of driving limitations by severity of better-
eye visual field loss. Upper and lower limits of box reflect the 75th
and 25th percentile values. Median values are shown by the
horizontal line within the box, and is not seen for the severe
glaucoma group as the median value is the same as the 75th
percentile. MD =mean deviation, dB = decibels.The presence of the association between glaucoma
and driving cessation found in the current work
corroborates previous studies. The Blue Mountain Eye
Study reported a greater than 2-fold increased odds of
driving cessation for subjects with glaucoma or impaired
visual acuity after adjusting for age and gender [16],
though subjects were not classified by disease severity.
The Salisbury Eye Evaluation found an association be-
tween bilateral glaucoma and driving cessation in the
elderly and a 2-fold greater risk of driving cessation with
every 5 dB decrement in the better-eye VF [14]. The
consistency of findings across studies supports the idea
that driving cessation becomes more common with
greater VF loss in numerous driving environments.
Previous studies have differed in their assessment of
whether people with glaucoma are more likely to limit
their driving. The Salisbury Eye Evaluation found no sig-
nificant associations between glaucoma and driving
limitations, but our study and two others did [12,14,15].
The discrepancies between different studies may be
explained by demographic differences in the study
populations. For example, our study population was
younger (mean age 70) and our study location was urban
while the Salisbury Eye Evaluation assessed an older
(mean age 80), rural group. The current study is the first
to demonstrate greater driving limitations with increas-
ing disease severity.
Driving cessation is clearly an effective method for
avoiding some of the risks associated with VF loss. How-
ever, the extent to which limitation of driving is a success-
ful method for balancing safety and independence remains
unknown. One possibility is that those who limit their
driving due to VF loss succeed in reducing their risk of
MVAs to a level similar to or even lower than other
drivers. This hypothesis could partially explain why some
previous studies found that having a glaucoma diagnosis
may not increase older individuals’ risk of MVAs [12,13].
However, a second possibility is that, despite limiting their
driving, individuals with glaucomatous VF loss still drive
poorly and/or unsafely. This is supported by studies
showing that VF loss is a risk factor for MVAs [9-11]. Fur-
ther study is needed to clarify the adequacy of these self-
imposed driving limitations in keeping drivers safe.
Another adaptation that drivers with glaucoma may
make is deferring to another driver. However, neither
glaucoma nor the severity of VF loss predicted driver
preference in the current study, which implies that glau-
coma is not a factor influencing driver preference inde-
pendent of other more significant factors such as gender
and age. As such, the selection of a driver within a fam-
ily may often be determined by traditional gender roles
rather than by driving skill.
Our study also identified several other non-visual
characteristics associated with driving habits. Depression
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risk factor for and a consequence of driving cessation
[14]. Females were more likely to limit their driving
[14,16,17]. Females, individuals living with another
driver, older individuals, and individuals with impaired
cognition were also more likely to prefer another driver.
These findings highlight the need to account for non-
visual factors when making recommendations regarding
driving.
The present study also sought to determine which
measure of vision best predicts driving limitations in
individuals with glaucoma. Contrast sensitivity appeared
to best predict driving cessation, so when information
on contrast sensitivity is available, it may be useful in
guiding conversations about driving. Contrast sensitivity
is highly correlated with better-eye VF MD in glaucoma
patients, however so the two measurements are essen-
tially interchangeable for this purpose.
The use of self-report to assess driving habits in this
study is a potential source of bias, as subjects may feel
motivated to conceal unsafe driving behaviors. It can
provide valuable information about subjects’ perceived
limitations, however, which may have a strong impact
on quality of life. Other studies have used simulators
and direct on-road evaluation to assess the impact of
glaucoma on driving [7,26-28]. These methodologies
have the advantage of allowing direct observation of
driving performance, thereby limiting self-report bias,
but offer a limited period of observation. Also, the driver
is not in their own car or typical driving environment,
which may impact their driving performance. The Salis-
bury Eye Evaluation Driving Study used driver
monitoring systems installed in subjects’ cars to study
the impact of vision on driving in a population-based
cohort of older adults [8]. While that study was not
powered to detect the impact of glaucoma on driving, it
represents a promising strategy for studying the impact of
vision loss on driving in the person’s native environment.
A limitation of our study was that driving changes
were not assessed prospectively, so we cannot draw
conclusions about the stage of disease at which driving
limitations and driving cessation first occurred. Also, our
control population was comprised of glaucoma suspects
rather than true ‘normals’ not under ophthalmologic
care. We felt that this was the best control group for our
study as it would balance any potential bias caused by
recruitment from a referral center. Additionally, normals
recruited from spouses or volunteers are likely to ex-
clude those with mobility limitations, thus overestimat-
ing findings. This suspect group reported minimal
driving limitations (6.9% driving cessation and an aver-
age of 1.1 driving limitations vs. 22.5% cessation and 1.9
limitations for the glaucoma group), suggesting that
these glaucoma suspects were not altering their drivinghabits due to knowledge of their disease risk. Finally, we
utilized better-eye VF loss as a metric of glaucoma sever-
ity instead of measures aimed at integrating right and
left eye VF results to simulate binocular VF loss. Previ-
ous work has shown that better-eye MD is typically
slightly worse than integrated VF MD, and differs from
integrated VF MD by 2 dB or more in roughly one in 4
patients [29,30]. Thus, it is possible that results would
have been different if integrated VF MD was used as a
metric of VF loss. However, binocular VF loss is not eas-
ily calculated in clinic and did not predict subjective or
objective measures of disability better than better-eye VF
loss in one study [31]. Better-eye MD has been shown to
predict legal fitness to drive in the United Kingdom just
as well as models which incorporated VF MDs from
both eyes [32], though further work will be necessary to
determine if better-eye and integrated VF metrics pre-
dict actual disability to a similar extent.
The choice to cease or limit driving is likely guided by
both fitness to drive and other factors. Regulating fitness
to drive is best achieved by combining information
regarding real-world patient choices and observation of
driving in simulated or real-world situations, and relat-
ing them to measures of VF loss [33]. The fact that
patients with glaucoma are more likely to limit their
driving is encouraging and may indicate that glaucoma
patients as a whole are self-regulating in such a way as
to keep themselves (and others) safe on the road. Fur-
ther prospective study is merited to assess when and
why people with glaucoma change their driving habits,
and perhaps to assess MVAs per mile driven in this
group. Because of the potential for driving cessation and
limitation to negatively affect individuals’ quality of life,
it will be important to balance safety and independence
for drivers with visual impairment due to glaucoma.
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